On August 28, 2025 Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, reported that management will participate in the following upcoming investor conferences (Press release, Alector, AUG 28, 2025, View Source [SID1234655541]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Global Healthcare Conference 2025 (New York, New York)
Thursday, September 4, 2025, at 3:55 p.m. ET, fireside chat
Morgan Stanley 23rd Annual Global Healthcare Conference (New York, New York)
Monday, September 8, 2025, at 10:00 a.m. ET, fireside chat
H.C. Wainwright 27th Annual Global Investment Conference (New York, New York)
Tuesday, September 9, 2025, at 1:30 p.m. ET, company presentation

A webcast of each conference presentation will be available on the "Events & Presentations" page within the Investors section of the Alector website at View Source Replays of the webcasts will be available on the Alector website for 90 days following the presentation dates.